Home › Idiopathic Thrombocytopenic Purpura › Massachusetts › Boston
Idiopathic Thrombocytopenic Purpura clinical trials in Boston, MA
6 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Massachusetts General Hospital, Boston
Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
RecruitingPhase 2
- Beth Israel Deaconess Medical Center, Boston
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
RecruitingPhase 2
- Beth Israel Deaconess Medical Center, Boston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Massachusetts General Hospital, Boston
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
RecruitingPhase 3
- Massachusetts General Hospital Cancer Center, Boston
- Beth Israel Deaconess Medical Center, Boston
Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia
RecruitingObservational study
- Massachusetts General Hospital, Boston
Idiopathic Thrombocytopenic Purpura trials in other cities
- Los Angeles, CA7 studies
- Greenville, NC6 studies
- Washington, DC6 studies
- The Bronx, NY5 studies
- Durham, NC4 studies
- Rochester, MN4 studies
- Seattle, WA4 studies
- Portland, OR4 studies
- Houston, TX4 studies
- Cedar Rapids, IA3 studies
- New Orleans, LA3 studies
- Cleveland, OH3 studies
Other studies in Boston
- Breast Cancer112 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)85 studies
- Metastatic Cancer63 studies
- Colorectal Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.